Myomo (MYO) Cash & Current Investments (2016 - 2025)
Myomo's (MYO) quarterly Cash & Current Investments came in at $19.0 million in Q4 2025, down 24.85% YoY from $25.2 million in Q4 2024, and up 46.72% on a QoQ basis from $12.9 million in Q3 2025.
Myomo (MYO) Cash & Current Investments (2016 - 2025) Analysis & Trends
Myomo (MYO) has 10 years of Cash & Current Investments data on file, last reported at $19.0 million in Q4 2025.
- Quarterly Cash & Current Investments fell 24.85% year-over-year to $19.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19.0 million (down 24.85% YoY) and the FY2025 annual result came in at $19.0 million, down 24.85% from the prior year.
- Cash & Current Investments grew to $19.0 million in Q4 2025, from $12.9 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $25.2 million in Q4 2024 to a low of $5.3 million in Q4 2022.
- A 5-year average of $13.1 million and a median of $12.3 million in 2021 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments tumbled 65.56% — and 2024, when it soared 184.69%.
- Tracing MYO's Cash & Current Investments over 5 years: stood at $15.5 million in 2021, then plunged by 65.56% to $5.3 million in 2022, then jumped by 65.84% to $8.9 million in 2023, then soared by 184.69% to $25.2 million in 2024, then decreased by 24.85% to $19.0 million in 2025.
- The last three Cash & Current Investments figures came in at $19.0 million (Q4 2025), $12.9 million (Q3 2025), and $16.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - | 18.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.97 Mn |
| Sep 30, 2025 | 12.93 Mn |
| Jun 30, 2025 | 16.72 Mn |
| Mar 31, 2025 | 24.47 Mn |
| Dec 31, 2024 | 25.24 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 8.98 Mn |
| Mar 31, 2024 | 10.96 Mn |
| Dec 31, 2023 | 8.87 Mn |
| Sep 30, 2023 | 11.12 Mn |
| Jun 30, 2023 | 11.91 Mn |
| Mar 31, 2023 | 9.26 Mn |
| Dec 31, 2022 | 5.35 Mn |
| Sep 30, 2022 | 7.42 Mn |
| Jun 30, 2022 | 10.24 Mn |
| Mar 31, 2022 | 12.94 Mn |
| Dec 31, 2021 | 15.52 Mn |
| Sep 30, 2021 | 12.61 Mn |
| Jun 30, 2021 | 13.77 Mn |
| Mar 31, 2021 | 17.37 Mn |